toujeo glp 1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 how does glp-1 stimulates insulin

PubMed Lazzerini M, Wanzira H

Wheeler AP, Ridley AJ

constipation, reflux, or intermittent nausea may continue Persistent or progressive symptoms rather than gradual improvement After month 3 Symptoms may remain mild or infrequent at a tolerated regimen New severe symptoms should not automatically be blamed on the medication The most important pattern is not simply "week 1 is bad and month 3 is good." A more accurate pattern is initiation, adaptation, possible symptom flare during dose escalation, and reassessment based on tolerability

The clinical pick depends on the patient's primary indication and the formulary's preferred-product designation

[29] Choline Choline requirements are exceptionally high in pregnant women